|
 |
ReneuronThis page contains recent news articles, when available, and an overview of Reneuron but does not offer medical advice. You should contact your physician with regard to any health issues or concerns.ReNeuron won UK government approval in January to test its ReN001 stem-cell line after three failures get permission from US regulators. ... BusinessWeek 454 Life Sciences plans R&D expansion: Surgeons plan test of ReNeuron stem ... - Dec 23, 2009 Bloomberg outlines researchers' plans to put ReNeuron's stem cell therapy to the test in 12 men disabled by a stroke. A neurosurgeon will inject two million ... FierceBiotech How our sector tips played out in 2009 - Dec 24, 2009 We waited for the excitement to fade, then tipped adult stem cell group Reneuron (Aim: RENE). It's up 25% since July. A potentially grave medical crisis ... MoneyWeek Financial Dynamics - ReNeuron to present ReN001 stroke programme at Royal ... - Oct 22, 2009 Guildford, UK, 22 October 2009: ReNeuron Group plc (LSE: RENE.L) announces that it will present its approach to the treatment of disabled stroke patients ... DeHavilland (press release) (subscription) A business locked in its cell - Nov 9, 2009 Not so, according to Michael Hunt, chief executive of ReNeuron, a spin-out from King's College London. “There are too few businesses coming through to ... Peninsula On-line Reportlinker Adds Regenerative Medicines: Bone and Joint Applications - Nov 3, 2009 251 RENEURON 252 RTI BIOLOGICS, INC. 252 SCIL TECHNOLOGY GMBH 252 SMITH AND NEPHEW 253 STEMCELLS, INC. 253 STEMCOR SYSTEMS, INC. 254 STRAUMANN USA LLC 254 ... IT News Online ReNeuron Group plc - Regulatory Update - Mar 19, 2008 RNS Number:4167Q ReNeuron Group plc 19 March 2008 PRESS RELEASE Regulatory update Guildford, UK, 19 March 2008: ReNeuron Group plc (LSE: RENE. ... Reuters UK ReNeuron raises £9.5m in return to market - Aug 6, 2005 By Rachel Stevenson. ReNeuron, the stem-cell research group, secured its return to the London stock market yesterday two years after going into private ... Independent ReNeuron on way back to stock market - Jul 13, 2005 By Rosie Murray-West, City Correspondent. Reneuron, the British stem cell pioneer owned by Sir Chris Evans' Merlin Biosciences, is planning a return to the ... Telegraph.co.uk ReNeuron Group plc - Research Update - Apr 23, 2008 RNS Number:8937S ReNeuron Group plc 23 April 2008 ReNeuron announces further pre-clinical data with its ReN003 programme for diseases of the retina ... Reuters UK Foetal cells 'to treat strokes' - Dec 5, 2006 Guildford-based ReNeuron has told the BBC it has convincing lab evidence that the ... The ReNeuron team have successfully extracted stem cells from the ... BBC News ReNeuron Group plc - Research Update - Feb 1, 2008 RNS Number:0522N ReNeuron Group plc 01 February 2008 Regulatory update Guildford, UK, 1 February 2008: ReNeuron Group plc (LSE: RENE. ... Reuters UK ReNeuron says confident of starting drug trial - Jun 27, 2007 LONDON, June 27 (Reuters) - Britain's ReNeuron Group Plc RENE.L said on Wednesday it was more confident of getting approval to trial a pioneering stem cell ... Reuters UK firm renews stem cell hope - Jul 13, 2005 But yesterday's news that UK-based specialist ReNeuron plans to return to the ... ReNeuron initially floated on the stock market in 2000 and was valued at ... guardian.co.uk UK small caps close lower; ReNeuron Group slumps on FDA information … - Jan 3, 2008 LONDON (Thomson Financial) - UK small caps finished lower today, bucking a resurgence among blue chips, with ReNeuron Group slumping as the US Food and Drug ... Forbes ReNeuron Announces Successful Completion Of Cell Banking With … - Mar 12, 2006 ReNeuron Group plc (LSE: RENE.L) today announces that it has successfully completed the scale-up and cell banking of its lead ReN001 stem cell product for ... Medical News Today - Medical News Today (press release) ReNeuron Group plc - Secures Funding. - Jan 24, 2007 RNS Number:0323Q ReNeuron Group plc 24 January 2007 ReNeuron secures funding from Michael J. Fox Foundation for ReN004 stem cell therapy for Parkinson's ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com ReNeuron Group plc - AGM Statement. - Sep 21, 2006 RNS Number:2860J ReNeuron Group plc 21 September 2006 Results of 2006 Annual General Meeting Guildford, UK, 21 September 2006: ReNeuron Group plc (LSE: ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com UK small caps close lower; Reneuron plummets on cash concerns - Apr 22, 2008 LONDON (Thomson Financial) - UK small caps closed lower, relinquishing yesterday's gains, as the wider market also sank lower, with Reneuron sent crashing ... Forbes Angel to scale up ReNeuron's stem cell lines - Feb 15, 2006 ReNeuron 's lead ReN001 cell line for chronic stroke disability has already been ... "We have a relationship with ReNeuron, we have qualified facilities, ... OutSourcing-Pharma.com Unlocking the secret of stem cells - Jul 17, 2005 ReNeuron is returning to the stock market just two years after being taken ... Nobody knows this better than ReNeuron, whose scientists are working on ... Telegraph.co.uk ReNeuron plans L5.5 million fundraising.(Brief article) - Feb 12, 2007 Guildford, UK-based stem cell therapy firm ReNeuron says it will place 18333333 new ordinary shares of 1 pence each, credited as fully-paid at a price of 30 ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Huntington's Disease - ReNeuron Signs Manufacturing Contract With … - Feb 8, 2006 ReNeuron Group plc (LSE: RENE.L) today announced that it has signed a manufacturing contract with Angel Biotechnology Holdings plc, the UK biopharmaceutical ... Medical News Today - Medical News Today (press release) ReNeuron Group plc - Regulatory Update. - Jan 9, 2007 RNS Number:1797P ReNeuron Group plc 09 January 2007 Regulatory Update Guildford, UK, 9 January 2007: ReNeuron Group plc (LSE: RENE) today provides an update ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com StemCells, Inc. Grants License to ReNeuron, Receives Stake in UK Stem... - Jul 6, 2005 PALO ALTO, Calif. -- StemCells, Inc. (NASDAQ: STEM) announced today that it has entered into an agreement with ReNeuron, a privately-owned UK biotech ... $4.95 - Business Wire - ECNext … Cell Transplantation Patent Application - Reneuron Receives Notice... - Jan 25, 2006 ReNeuron Group plc (LSE: RENE.L) today announced that it has received a Notice of ... ReNeuron is a leading, UK-based adult stem cell therapy business. ... Medical News Today - Medical News Today (press release) ReNeuron awarded EU stem cell patents - Apr 18, 2007 By Dr Matt Wilkinson, 18-Apr-2007. The European Union Patent Office (EPO) has granted UK stem cell experts ReNeuron patent protection for three key human ... DrugResearcher.com ReNeuron Group PLC holds key meeting with the FDA regarding its … - Sep 26, 2005 ReNeuron Group plc (LSE: RENE.L) today announced that it has held a formal pre-IND1 meeting with the CBER2 component of the US Food & Drug Administration ... Medical News Today - Medical News Today (press release) ReNeuron Inks Collaboration Agreement with CellSeed - Nov 30, 2006 ReNeuron and CellSeed signed a collaboration agreement to develop liver-cell culture systems for drug safety screening in the pharmaceutical industry. ... Genetic Engineering News - Genetic Engineering News (press release) ReNeuron Regulatory Update - Jan 2, 2008 Guildford, UK, 1 February 2008:ReNeuron Group plc (LSE: RENE.L) today provides an update on progress with its Investigational New Drug (IND) application to ... FierceBiotech ReNeuron Holdings PLC acquires Amcyte Inc - Deal Snapshot - … - Jul 27, 2007 US - ReNeuron Group plc acquired Amcyte Inc, a biotechnology company, for $# mil.: Mergers & Acquisitions, Deal Snapshot. Pay-Per-View - deals - Alacra Store DEAD TOT 'CURE' FOR STROKES - Dec 6, 2006 The UK biotech company ReNeuron is seeking permission from American regulators for trials next year. They will involve taking stem cells from the developing ... Mirror.co.uk ReNeuron and Millipore launch neural stem-cells.(Brief article) - Nov 27, 2006 UK stem-cell specialist ReNeuron and USA-based Millipore Corp have announced the market launch of the former's ReNcell neural stem cell lines for use in ... Free with registration - Pharma Marketletter - AccessMyLibrary.com ReNeuron comments on research highlighting contamination of certain … - Jan 27, 2005 January 26, 2005, Surrey, UK - ReNeuron, the UK-based stem cell research and development company, has noted the recent publication in Nature Medicine of ... Medical News Today - Medical News Today (press release) Article: ReNeuron ; THE INVESTMENT COLUMN - The Independent - … - Jan 10, 2007 ReNeuron ; THE INVESTMENT COLUMN ... find The Independent - London articles. Our view: Hold Share price: 37.75p (-6.75p) ReNeuron is a pioneer in the area ... Pay-Per-View - Independent - London - HighBeam Research ReNeuron Group plc - Exercise of Warrants. - Nov 15, 2006 RNS Number:0881M ReNeuron Group plc 15 November 2006 Exercise of Warrants Guildford, UK, 15 November 2006: ReNeuron Group plc (LSE: RENE) gives notice ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com ReNeuron acquires Californian base and new diabetes technology - Aug 2, 2007 Pioneering British stem cell research company ReNeuron has bought the Californian company, AmCyte - a move it hopes will make it a world-leader in stem cell ... Pharmafocus Replidyne axes licensing deal; ReNeuron raises funds; - Jun 24, 2008 ...> Replidyne has axed a licensing deal with Asubio Pharma and says it expects to take a charge of $4.1 million after failing to find a partner for faropenem. ... FierceBiotech ReNeuron relisted on AIM.(Alternative Investment Market)(Brief... - Aug 1, 2005 In an optimistic move, UK stem cell company ReNeuron, in Guildford, announced plans to relist on the London Stock Exchange's Alternative Investment Market ... Free with registration - Chemistry and Industry - AccessMyLibrary.com ReNeuron buys Amcyte assets for $4M. - Aug 6, 2007 Guildford, UK-based ReNeuron Group has entered into arrangements to acquire the business assets of AmCyte Inc, a US development-stage cell therapy company ... Free with registration - Pharma Marketletter - AccessMyLibrary.com RENEURON REPORTS REN004 DATA PROMISING FOR PARKINSON'S … - Apr 1, 2006 ReNeuron Group plc (LSE: RENE),Guildford, UK, has announced that initial in vivo testing of its ReN004 candidate stem cell lines shows them to have ... Free with registration - Worldwide Biotech - AccessMyLibrary.com RENEURON News RENE RENE.L - Interactive Investor - Jan 3, 2008 LONDON (Thomson Financial) - ReNeuron Group PLC said its Investigational New Drug application to US regulators for its stem-cell therapy to treat strokes is ... Interactive Investor ReNeuron reports losses of $L4.3 million.(Brief Article) - Dec 12, 2005 UK-based ReNeuron, a specialist stem-cell developer, says its net loss for the six months ended September 30, 2005, was L4.3 million ($7.5 million) up from ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Angel announces manufacturing contract with ReNeuron - May 29, 2008 Angel Biotechnology, the biopharmaceutical contract manufacturer, has picked up a new manufacturing contract with fellow AIM company ReNeuron Group. ... SmallCapNews.co.uk ReNeuron 'confident' in stem cell therapy, despite delay - Jan 17, 2007 By Mike Nagle, 17-Jan-2007. ReNeuron remains confident that its new stem cell therapy for stroke will be approved to start clinical trials, ... DrugResearcher.com ReNeuron completes banking of stem cell therapy - Mar 10, 2006 By Wai Lang Chu, 10-Mar-2006. The ReNeuron Group has announced it has completed the scale-up and cell banking of its lead stem cell product for stroke, ... In-PharmaTechnologist.com ReNeuron announces first results from key pre-clinical safety studies... - Nov 20, 2005 ReNeuron Group plc (LSE: RENE.L) today announced that it has generated provisional pre-clinical data indicating that its lead ReN001 cell line for stroke ... Medical News Today - Medical News Today (press release) ReNeuron's reverberations. | Article from Investors Chronicle -... - May 21, 2008 ReNeuron is in the forefront of stem cell treatments although its share price is ... "Take ReNeuron and Stem Cell Sciences. They will need to come back ... ... Pay-Per-View - Investors Chronicle - magazine and web... - HighBeam Research ReNeuron Group Plc announces Market Launch of ReNcell - Nov 17, 2006 Guildford, UK, 20 November 2006: ReNeuron Group plc (LSE: RENE.L) and Millipore Corporation (NYSE: MIL), announce the market launch of ReNeuron's patented ... Genetic Engineering News - Genetic Engineering News (press release) ReNeuron Takes Over AmCyte for $4M - Jul 27, 2007 ReNeuron reported plans to buy the business assets of AmCyte, a development-stage cell therapy company, in a transaction worth about $4 million. ... Genetic Engineering News - Genetic Engineering News (press release) Stem cell company floats on aim.(ReNeuron)(Brief Article) - Sep 1, 2005 ReNeuron, a Merlin Biosciences-backed biotech company, has floated on the London Stock Exchange's Alternative Investment Market (AIM) market with a market ... Free with registration - European Venture Capital Journal - AccessMyLibrary.com ReNeuron Group plc - Director/PDMR Shareholding. - Dec 7, 2006 RNS Number:4107N ReNeuron Group plc 07 December 2006 Director Share Purchases Guildford, UK, 6 December 2006: ReNeuron Group plc (LSE: RENE) today announces ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com UK smallcap opening - ReNeuron climbs on US patent grant - May 21, 2008 LONDON (Thomson Financial) - ReNeuron Group provided an early feature, climbing 2-1/2 pence to 13-1/4 after the company received a notification of grant ... London South East ALSO NOTED: ReNeuron confident of trial OK; Valeant licenses Xyrem … - Jan 11, 2007 ...> ReNeuron Group says it is confident that it can gain regulatory approval to start a Phase I stem cell trial of ReN001 after the FDA put a hold on the ... FierceBiotech ReNeuron relisted on AIM.(Alternative Investment Market)(Brief... - Aug 1, 2005 ReNeuron relisted on AIM.(Alternative Investment Market)(Brief Article) ... find Chemistry and Industry articles. In an optimistic move, ... Pay-Per-View - Chemistry and Industry - HighBeam Research Reneuron signs deal with Chemicon. - Apr 21, 2006 Stem-cell technology specialist Reneuron has signed an agreement with Chemicon which will market and supply its stem-cell lines worldwide. ... Free with registration - Investors Chronicle - AccessMyLibrary.com ReNeuron's battle. - Dec 4, 2007 ReNeuron is edging closer to its near-term goal of being the first company to be involved in clinical-stage research for stem-cell treatment for a major ... Free with registration - Investors Chronicle - magazine and web... - AccessMyLibrary.com ReNeuron receives patent from US PTO. - May 26, 2008 ReNeuron receives patent from US PTO. UK stem-cell specialist ReNeuron has received a patent from the US Patent and Trademark Office for its ReN002 program, ... $9.94 - Pharma Marketletter - Alacra Store ReNeuron Group plc - Notice of Results. - Nov 22, 2006 RNS Number:5427M ReNeuron Group plc 22 November 2006 ReNeuron plc Notification of Interim Results Guildford, UK, 22 November 2006: ReNeuron Group plc (LSE: ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com … .(Special Section: Opthalmic Pipeline)(ReNeuron Ltd.)(Brief article) - Jul 1, 2006 Guildford, England -- ReNeuron Group plc has announced initial survival efficacy ... In order to further its ReN003 retinal stem cell program, ReNeuron has ... Free with registration - Ophthalmology Times - AccessMyLibrary.com RENEURON (RENE) - Dec 15, 2006 ..."We've never been here before," admits ReNeuron chief executive Michael Hunt. He's referring to the fact that the adult stem-cell company has moved closer ... Investors Chronicle ReNeuron's six-month loss down 26%.(Financial report)(Brief article) - Dec 18, 2006 UK-based stem-cell specialist ReNeuron says that, for the six months ended ... ReNeuron went on to say that the worldwide launch of its ReNcell neural cell ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Stem cell research faces setback.(Regulatory concerns)(ReNeuron)(Brief... - Jan 29, 2007 According to ReNeuron, the points raised by the FDA were largely expected and are readily addressable, but the company is waiting for the FDA to confirm in ... Free with registration - Chemistry and Industry - AccessMyLibrary.com ReNeuron signs contract manufacturing deal with Angel.(Brief Article) - Feb 13, 2006 Stem cell therapeutics specialist ReNeuron has signed a manufacturing contract with fellow UK-based Angel Biotechnology Holdings, a biopharmaceutical ... Free with registration - Pharma Marketletter - AccessMyLibrary.com Strong preclinical data for ReNeuron's ReN003.(ReN003 stem cell … - Apr 17, 2006 UK-based stem cell specialist ReNeuron has reported postitive initial survival ... In order to further its ReN003 retinal stem cell program, ReNeuron has ... Free with registration - Pharma Marketletter - AccessMyLibrary.com ReNeuron's ReN001 on clinical hold by FDA.(Food and Drug … - Jan 22, 2007 However, ReNeuron is confident that its IND will be cleared. ... According to a ReNeuron press statement, the points raised during the initial ... Free with registration - Pharma Marketletter - AccessMyLibrary.com ReNeuron generates pancreatic cell lines for diabetes.(Brief article) - Jul 2, 2007 Guildford, UK-based ReNeuron says that it has taken a major step forward with its ReN002 diabetes program with the generation of new data concerning its ... Free with registration - Pharma Marketletter - AccessMyLibrary.com ReNeuron Group plc - Holding(s) in Company. - Aug 30, 2006 RNS Number:2338I ReNeuron Group plc 30 August 2006 Letter to: ReNeuron Group plc Dated: 17 August 2006 Notification pursuant to s198 Companies Act 1985 ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com ReNeuron on track to seek go ahead for first stem cell stroke trials... - Sep 22, 2005 ReNeuron Group PLC is on track to file for permission from US regulators to start testing its lead stem cell therapy, to treat chronic disability after ... Pay-Per-View - Company Reports - Factiva, from Dow Jones ReNeuron Group plc - Director/PDMR Shareholding. - Sep 4, 2006 RNS Number:4671I ReNeuron Group plc 04 September 2006 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com ReNeuron Group plc - Holding(s) in Company. - Mar 23, 2007 RNS Number:5875T ReNeuron Group plc 23 March 2007 TR-1: NOTIFICATION OF MAJOR INTERESTS IN SHARES (1). Identity of the issuer or the underlying issuer of ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com ReNeuron leads the way. | Article from Investors Chronicle - magazine... - Jul 4, 2007 ReNeuron leads the way. ... find Investors Chronicle - magazine and web content articles. ReNeuron is in the forefront of stem cell treatments although its ... Pay-Per-View - Investors Chronicle - magazine and web... - HighBeam Research UK smallcap opening - Angel Biotech up ReNeuron agreement. - Aug 9, 2006 The consortium, led by ReNeuron, is undertaking a bioprocessing project entitled Therapeutic Products from Human Stem Cells in which Angel is the ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com ReNeuron granted US stem cell brain repair patent.(United States'... - Jan 30, 2006 Guildford, UK-based ReNeuron has received a notice of allowance from the US Patent and Trademark Office concerning a key patent application for methods of ... Free with registration - Pharma Marketletter - AccessMyLibrary.com ReNeuron, CellSeed to collaborate on development of liver cell... - Nov 30, 2006 LONDON (AFX) - ReNeuron Group plc and CellSeed Inc, a privately owned tissue engineering company based in Tokyo, Japan, said they are going to collaborate ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com ReNeuron and CellSeed to develop stem cell-based drug assays.( … - Dec 4, 2006 UK-based stem cell specialist ReNeuron and CellSeed, a privately-owned Japanese tissue engineering firm, say they have established a collaboration agreement ... Free with registration - Pharma Marketletter - AccessMyLibrary.com ReNeuron Group plc - Director/PDMR Shareholding. - Dec 7, 2006 RNS Number:4108N ReNeuron Group plc 07 December 2006 NOTIFICATION OF TRANSACTIONS OF DIRECTORS, PERSONS DISCHARGING MANAGERIAL RESPONSIBILITY OR CONNECTED ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com ReNeuron Group plc - Holding(s) in Company. - Aug 30, 2006 RNS Number:2349I ReNeuron Group plc 30 August 2006 Letter to ReNeuron Group PLC dated 30 August 2006 AIM REALISATION FUND LIMITED (the "Company") As manager ... Free with registration - Europe Intelligence Wire - AccessMyLibrary.com RENEURON (RENE). | Article from Investors Chronicle | HighBeam … - Dec 15, 2006 RENEURON (RENE). ... find Investors Chronicle articles. "We've never been here before," admits ReNeuron chief executive Michael Hunt. Pay-Per-View - Investors Chronicle - HighBeam Research ReNeuron reports more data on ReN003. - Apr 28, 2008 ReNeuron reports more data on ReN003. UK company, ReNeuron, has announced further preclinical data for its stem cell therapy program for diseases of the ... $9.94 - Pharma Marketletter - Alacra Store FDA puts ReNeuron's Ph I US ReN001 trial on clinical hold.(Brief... - Jan 15, 2007 Guildford, UK-based stem cell specialist ReNeuron has had a Phase I clinical study of its ReN001 stem cell therapy for stroke placed on clinical hold by the ... Free with registration - Pharma Marketletter - AccessMyLibrary.com UK smallcap opening - ReNeuron pushes ahead on diabetes results - Jun 22, 2007 LONDON (Thomson Financial) - A positive result in its diabetes treatment pushed ReNeuron Group 2 higher at 24-1/2, as the stem cell therapy company ... Interactive Investor ReNeuron Group.(Phase I) - Feb 1, 2007 After placing ReNeuron Group's (Guildford, UK) proposed Phase I trial of ReN001 for stroke on hold, in early January the FDA asked for additional ... Free with registration - Applied Clinical Trials - AccessMyLibrary.com UK smallcap opening - ReNeuron rises on research update - Sep 6, 2007 LONDON (Thomson Financial) - ReNeuron Group attracted support and rose 2 pence to 22-1/2 following the successful completion of pre-clinical trials for the ... London South East ReNeuron's ReN001 sees good efficacy data.(Brief Article) - Feb 13, 2006 Guildford, UK-based ReNeuron says that ReN001, its candidate stem cell therapy for stroke, has generated further positive preclinical efficacy data. ... Free with registration - Pharma Marketletter - AccessMyLibrary.com ReNeuron gets funding for ReN004 from foundation. - Jan 29, 2007 ReNeuron gets funding for ReN004 from foundation. Guildford, UK-headquartered ReNeuron Group says that it has been awarded a grant from the USA-based ... $9.94 - Pharma Marketletter - Alacra Store ReNeuron admitted to AIM.(Alternative Investment Market)(Brief... - Aug 22, 2005 Guildford, UK-based ReNeuron has announced that trading in the company's ordinary shares and warrants will commence on August 12 on London's Alternative ... $4.95 - Pharma Marketletter - ECNext Angel announces GMP manufacturing contract with ReNeuron - Jul 3, 2007 All I will say is you need to do some serious research here, RNS stated "Drilling operations commenced on the 20th August 2007 and are anticipated to ... London South East … faces setback.(Regulatory concerns)(ReNeuron)(Brief article) -... - Jan 29, 2007 Regulatory concerns)(ReNeuron)(Brief article) ... find Chemistry and Industry articles. British stem cell company ReNeuron's plans to commercialise its stem ... Pay-Per-View - Chemistry and Industry - HighBeam Research ReNeuron's losses for full year 2005 hit L6.3M. - Jul 10, 2006 UK-based stem-cell specialists ReNeuron says that its losses for the year ... ReNeuron also reported that promising efficacy data from preclinical trials of ... $9.94 - Pharma Marketletter - Alacra Store ReNeuron leads the way. - Jul 4, 2007 ReNeuron is in the forefront of stem cell treatments although its share price is well down from its end-2007 high. Nigel Bolitho ... $4.95 - Investors Chronicle - magazine and web... - ECNext ReNeuron gains revenue-share on new cell line patent. - Mar 5, 2007 ReNeuron gains revenue-share on new cell line patent. UK-based ReNeuron has entered into a revenue-sharing agreement with the international Ludwig Institute ... $9.94 - Pharma Marketletter - Alacra Store ReNeuron reports flat six-month net loss. - Dec 8, 2008 ReNeuron reports flat six-month net loss. UK stem cell specialist ReNeuron says its loss for the six months ended September 30, 2008, was L3.1 million ($4.6 ... $9.94 - Pharma Marketletter - Alacra Store FLOAT OF THE WEEK - Reneuron set to refloat. - Jul 15, 2005 When Reneuron's diabetic neuropathy drug flunked trials in 2003, it looked as though the stem-cell company would go bust. At the time, former chief ... $4.95 - Investors Chronicle - ECNext ReNeuron enters cross-licence with StemCells.(Brief Article) - Jul 11, 2005 ReNeuron, a UK-based adult stem-cell R&D firm, has entered into an agreement with StemCells, a US adult stem cell development company, giving the latter ... $4.95 - Pharma Marketletter - ECNext ReNeuron files world's first neural stem cell therapy IND with FDA. - Dec 22, 2006 ReNeuron files world's first neural stem cell therapy IND with FDA. UK-based stem-cell therapeutics developer ReNeuron says it has filed an Investigational ... $9.94 - Pharma Marketletter - Alacra Store ReNeuron Group plc; Pharma company holds preIND application meeting … - Oct 26, 2005 2005 OCT 26 - (NewsRx.com) -- ReNeuron Group plc (RENE.L) announced that it has held a formal preinvestigational new drug application (IND) meeting with the ... Pay-Per-View - Biotech Week - Factiva, from Dow Jones ReNeuron's fiscal 2007 net loss narrows 18.7%. - Jul 9, 2007 Commenting on the results, Trevor Jones, chairman of the firm, said: "the period under review has been a significant one for ReNeuron, with our ReN001 ... $9.94 - Pharma Marketletter - Alacra Store Article: FLOAT OF THE WEEK - Reneuron set to refloat. - Investors … - Jul 15, 2005 FLOAT OF THE WEEK - Reneuron set to refloat. ... find Investors Chronicle articles. When Reneuron's diabetic neuropathy drug flunked trials in 2003, ... Pay-Per-View - Investors Chronicle - HighBeam Research Major US stem cell project signs up UK-based firm - Oct 19, 2006 ReNeuron, which is based in the UK, is the only private company asked to work on the ... ReNeuron is advising the group, The Daily Telegraph has learned. ... Telegraph.co.uk ReNeuron to list of UK's AIM market.(Alternative Investment Market)(Br... - Jul 25, 2005 ReNeuron Group has announced its intention to list on the UK's Alternative Investment Market via an institutional placing of L10.0 million ($17.5 million) ... $4.95 - Pharma Marketletter - ECNext ReNeuron completes flotation.(Brief Article) - Aug 15, 2005 ReNeuron, a UK-based adult stem cell company says it has successfully completed its flotation on London's Alternative Investment Market. ... $4.95 - Pharma Marketletter - ECNext ReNeuron consortium gets L2.2M grant for stem-cell therapy.(Brief... - Jan 17, 2005 Privately-held, UK-based stem cell research group ReNeuron says that a consortium which it leads has been awarded a L2.2 million ($4.1 million) grant from ... $4.95 - Pharma Marketletter - ECNext ReNeuron seeks FDA approval for ReN001.(ReNeuron Holdings PLC)( … - Oct 3, 2005 UK-based stem cell development firm ReNeuron has announced the completion of pre-Investigational New Drug talks with the US Food and Drug Administration ... $4.95 - Pharma Marketletter - ECNext ReNeuron's ReN001: good in vivo safety.(cell line for implantation... - Nov 28, 2005 Guildford, UK-based stem-cell specialist ReNeuron has generated provisional preclinical data indicating that its lead ReN001 cell line for implantation ... Pay-Per-View - Pharma Marketletter - Factiva, from Dow Jones Broker's pioneer fund AIMs to stop rot - Sep 24, 2006 One such company, he said, is ReNeuron, whose flotation Collins Stewart handled ... This is the second time ReNeuron has been listed; it was delisted by ... Independent |
|
Health Home | Conditions | Cancer | Medications | Surgery | Vaccines The Cancer News Network
COPYRIGHT 2009 CANCERNEWSNETWORK | Privacy |